GP5 Technology Highlights

Screenshot

Successful in vitro tests in Norway at our Glucare consortium partner ZP
Big news from the lab!
We’re excited to share that our in vitro tests at Zimmer & Peacock (ZP) in Norway have shown highly promising results. These tests confirm the stability and biocompatibility of our GP5 coating technology under clinically relevant conditions.

Zimmer and Peacock is a valued member of our Glucare consortium. Their work on sensor interface validation and in vitro testing strengthens the scientific foundation behind GP5 and supports its future clinical applicability.